Insider Transactions in Q1 2019 at Amgen Inc (AMGN)
Insider Transaction List (Q1 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 22
2019
|
Robert A Bradway Chairman, CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
25,268
-5.25%
|
$4,826,188
$191.89 P/Share
|
|
Mar 22
2019
|
Jonathan P Graham EVP & Gen. Counsel & Secy. |
SELL
Payment of exercise price or tax liability
|
Direct |
5,283
-10.09%
|
$1,009,053
$191.89 P/Share
|
|
Mar 22
2019
|
David W Meline EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,040
-12.77%
|
$1,535,640
$191.89 P/Share
|
|
Mar 22
2019
|
Cynthia M Patton SVP & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,515
-5.44%
|
$289,365
$191.89 P/Share
|
|
Mar 22
2019
|
David Piacquad SVP, Business Development |
SELL
Payment of exercise price or tax liability
|
Direct |
1,509
-3.16%
|
$288,219
$191.89 P/Share
|
|
Mar 22
2019
|
David M Reese EVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,769
-5.12%
|
$337,879
$191.89 P/Share
|
|
Mar 22
2019
|
Esteban Santos EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,838
-4.84%
|
$351,058
$191.89 P/Share
|
|
Mar 06
2019
|
Robert A Bradway Chairman, CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
50,557
+9.51%
|
-
|
|
Mar 06
2019
|
Jonathan P Graham EVP & Gen. Counsel & Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
10,570
+16.86%
|
-
|
|
Mar 06
2019
|
David W Meline EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
16,086
+20.41%
|
-
|
|
Mar 06
2019
|
Cynthia M Patton SVP & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
3,676
+11.69%
|
-
|
|
Mar 06
2019
|
David Piacquad SVP, Business Development |
BUY
Grant, award, or other acquisition
|
Direct |
3,676
+7.16%
|
-
|
|
Mar 06
2019
|
David M Reese EVP & Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,676
+9.67%
|
-
|
|
Mar 06
2019
|
Esteban Santos EVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
3,676
+8.85%
|
-
|
|
Mar 06
2019
|
Ronald D Sugar Director |
SELL
Open market or private sale
|
Direct |
2,000
-13.34%
|
$376,000
$188.88 P/Share
|
|
Mar 06
2019
|
Ronald D Sugar Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+11.77%
|
$108,000
$54.71 P/Share
|
|
Feb 07
2019
|
Lori A Johnston EVP, HR |
SELL
Payment of exercise price or tax liability
|
Direct |
454
-2.63%
|
$86,260
$190.76 P/Share
|
|
Feb 07
2019
|
Ronald D Sugar Director |
SELL
Open market or private sale
|
Direct |
2,000
-13.34%
|
$380,000
$190.0 P/Share
|
|
Feb 07
2019
|
Ronald D Sugar Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+11.77%
|
$108,000
$54.71 P/Share
|
|
Feb 01
2019
|
Charles M Holley Director |
BUY
Grant, award, or other acquisition
|
Direct |
106
+6.43%
|
-
|
|
Feb 01
2019
|
Ellen Jamison Kullman Director |
BUY
Grant, award, or other acquisition
|
Direct |
187
+5.05%
|
-
|
|
Jan 30
2019
|
Robert A Bradway Chairman, CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,625
-0.38%
|
$312,000
$192.11 P/Share
|
|
Jan 30
2019
|
David W Meline EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
528
-1.12%
|
$101,376
$192.11 P/Share
|
|
Jan 30
2019
|
Cynthia M Patton SVP & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
117
-0.48%
|
$22,464
$192.11 P/Share
|
|
Jan 30
2019
|
David Piacquad SVP, Business Development |
SELL
Payment of exercise price or tax liability
|
Direct |
162
-0.37%
|
$31,104
$192.11 P/Share
|
|
Jan 30
2019
|
David M Reese EVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
115
-0.37%
|
$22,080
$192.11 P/Share
|
|
Jan 30
2019
|
Esteban Santos EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
142
-0.41%
|
$27,264
$192.11 P/Share
|